Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 363

1.

Development of Safe and Effective Botanical Dietary Supplements.

van Breemen RB.

J Med Chem. 2015 Jun 30. [Epub ahead of print]

PMID:
26125082
2.

Too little, too late: ineffective regulation of dietary supplements in the United States.

Starr RR.

Am J Public Health. 2015 Mar;105(3):478-85. doi: 10.2105/AJPH.2014.302348. Epub 2015 Jan 20.

PMID:
25602879
3.

Pharmacological approaches to the management of binge eating disorder.

Brownley KA, Peat CM, La Via M, Bulik CM.

Drugs. 2015 Jan;75(1):9-32. doi: 10.1007/s40265-014-0327-0.

PMID:
25428709
4.

Presence of banned drugs in dietary supplements following FDA recalls.

Cohen PA, Maller G, DeSouza R, Neal-Kababick J.

JAMA. 2014 Oct 22-29;312(16):1691-3. doi: 10.1001/jama.2014.10308. No abstract available.

PMID:
25335153
5.

Probiotics: achieving a better regulatory fit.

Hoffmann DE, Fraser CM, Palumbo F, Ravel J, Rowthorn V, Schwartz J.

Food Drug Law J. 2014;69(2):237-72, ii.

PMID:
25163211
6.
7.

Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem.

Council on Environmental Health, Rogan WJ, Paulson JA, Baum C, Brock-Utne AC, Brumberg HL, Campbell CC, Lanphear BP, Lowry JA, Osterhoudt KC, Sandel MT, Spanier A, Trasande L.

Pediatrics. 2014 Jun;133(6):1163-6. doi: 10.1542/peds.2014-0900. Review.

8.

Proposed actions for the US Food and Drug Administration to implement to minimize adverse effects associated with energy drink consumption.

Thorlton J, Colby DA, Devine P.

Am J Public Health. 2014 Jul;104(7):1175-80. doi: 10.2105/AJPH.2014.301967. Epub 2014 May 15.

PMID:
24832439
9.

Melatonin for the treatment of irritable bowel syndrome.

Siah KT, Wong RK, Ho KY.

World J Gastroenterol. 2014 Mar 14;20(10):2492-8. doi: 10.3748/wjg.v20.i10.2492. Review.

10.

The Institute of Medicine, the Food and Drug Administration, and the calcium conundrum.

Neupane S, Knohl SJ.

Public Health Nutr. 2014 Aug;17(8):1865-7. doi: 10.1017/S1368980014000184. Epub 2014 Mar 12.

PMID:
24621615
11.

Review: probiotics and their beneficial effects against various diseases.

Iqbal MZ, Qadir MI, Hussain T, Janbaz KH, Khan YH, Ahmad B.

Pak J Pharm Sci. 2014 Mar;27(2):405-15. Review.

PMID:
24577933
12.

We really need to talk: adapting FDA processes to rapid change.

Lykken S.

Food Drug Law J. 2013;68(4):357-99, i.

PMID:
24552079
13.

Folic acid fortification and colorectal cancer risk.

Keum N, Giovannucci EL.

Am J Prev Med. 2014 Mar;46(3 Suppl 1):S65-72. doi: 10.1016/j.amepre.2013.10.025.

14.

Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver.

Seldin MM, Lei X, Tan SY, Stanson KP, Wei Z, Wong GW.

J Biol Chem. 2013 Dec 13;288(50):36073-82. doi: 10.1074/jbc.M113.500736. Epub 2013 Nov 1.

15.

Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes.

Fenton JI, Hord NG, Ghosh S, Gurzell EA.

Prostaglandins Leukot Essent Fatty Acids. 2013 Nov-Dec;89(6):379-90. doi: 10.1016/j.plefa.2013.09.011. Epub 2013 Sep 30. Review.

16.

Science and regulation. Probiotics: finding the right regulatory balance.

Hoffmann DE, Fraser CM, Palumbo FB, Ravel J, Rothenberg K, Rowthorn V, Schwartz J.

Science. 2013 Oct 18;342(6156):314-5. doi: 10.1126/science.1244656. No abstract available. Erratum in: Science. 2013 Nov 8;342(6159):693.

PMID:
24136953
17.

The immuno-regulatory impact of orally-administered Hypericum perforatum extract on Balb/C mice inoculated with H1n1 influenza A virus.

Huang N, Singh N, Yoon K, Loiacono CM, Kohut ML, Birt DF.

PLoS One. 2013 Sep 30;8(9):e76491. doi: 10.1371/journal.pone.0076491. eCollection 2013.

18.

Vitamin and supplement do's and don'ts.

[No authors listed]

Consum Rep. 2013 Oct;78(10):8-9. No abstract available.

PMID:
24032178
19.

Thyroxine and triiodothyronine content in commercially available thyroid health supplements.

Kang GY, Parks JR, Fileta B, Chang A, Abdel-Rahim MM, Burch HB, Bernet VJ.

Thyroid. 2013 Oct;23(10):1233-7. doi: 10.1089/thy.2013.0101. Epub 2013 Sep 14.

PMID:
23758055
20.

Icosapent ethyl for the treatment of hypertriglyceridemia.

Ballantyne CM, Braeckman RA, Soni PN.

Expert Opin Pharmacother. 2013 Jul;14(10):1409-16. doi: 10.1517/14656566.2013.798645. Epub 2013 May 24.

PMID:
23701295
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk